CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 11,713,338	$ 15,612,391
Short term investments	555	512
Restricted cash	1,427,827	3,381,369
Accounts receivable trade, net of allowance for doubtful accounts of $437,443 and $210,977, respectively	8,944,803	5,871,474
Inventory	20,582,284	21,023,388
Deferred income taxes	621,105
Prepaids and other current assets	1,808,695	993,711
Total current assets	45,098,607	46,882,845
Property, plant and equipment, net	49,571,589	36,998,241
Land use rights, net	4,870,549	4,807,834
Goodwill	32,586,656	27,002,044
Intangible assets, net	30,461,547	24,466,597
Other assets	5,625,734	2,867,188
Assets, Total	168,214,682	143,024,749
Current Liabilities
Accounts payable	9,896,278	14,286,929
Accrued liabilities	5,863,031	2,772,019
Bank loans	7,810,000	3,034,000
Notes payable	3,766,272	9,568,398
Mortgages payable - current	187,935
Income taxes payable	589,230	1,242,911
Deferred income taxes	338,054	232,075
Unearned revenues	3,066,851	1,708,280
Total current liabilities	31,517,651	32,844,612
Long-term Liabilities
Deferred income taxes	5,655,744	5,959,508
Deferred rent liability	10,743	45,489
Unearned revenues	180,808	282,518
Mortgages payable	3,487,175
Derivative liabilities	910,318	2,571,367
Amount due related parties	20,534,147	8,301,361
Total long-term liabilities	30,778,935	17,160,243
Commitments and Contingencies
Redeemable Securities
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 7,838,527 and 10,582,011 shares, at September 30, 2011 and December 31, 2010, respectively	5,475,567	6,532,275
Temporary Equity, Carrying Amount, Total	5,475,567	6,532,275
Shareholders' Equity
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at September 30, 2011 and December 31, 2010	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 100,361,443 and 64,221,130 shares, at September 30, 2011 and December 31, 2010, respectively	100,361	63,813
Additional paid-in capital	192,575,872	141,137,522
Accumulated deficit	(124,116,505)	(95,320,620)
Accumulated other comprehensive income	5,001,635	2,779,066
Total NeoStem, Inc. shareholders' equity	73,561,463	48,659,881
Noncontrolling interests	26,881,066	37,827,738
Total equity	100,442,529	86,487,619
Liabilities and Equity, Total	$ 168,214,682	$ 143,024,749